The effect of small-molecule inhibition of MAPKAPK2 on cell ageing phenotypes of fibroblasts from human Werner syndrome
<p>Abstract</p> <p>Fibroblasts derived from the progeroid Werner syndrome (WS) show reduced replicative lifespan and a “stressed” morphology, both phenotypes being alleviated by using the p38 MAP kinase inhibitor SB203580. Because p38 is a major hub for the control of stress-signal...
Main Authors: | Davis Terence, Rokicki Michal J, Bagley Mark C, Kipling David |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-01-01
|
Series: | Chemistry Central Journal |
Subjects: | |
Online Access: | http://journal.chemistrycentral.com/content/7/1/18 |
Similar Items
-
Microwave-Assisted Synthesis of a MK2 Inhibitor by Suzuki-Miyaura Coupling for Study in Werner Syndrome Cells
by: Mark C. Bagley, et al.
Published: (2015-06-01) -
Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome
by: Mark C. Bagley, et al.
Published: (2010-06-01) -
MAPKAPK2 plays a crucial role in the progression of head and neck squamous cell carcinoma by regulating transcript stability
by: Sourabh Soni, et al.
Published: (2019-04-01) -
MK2 Inhibitors as a Potential Crohn’s Disease Treatment Approach for Regulating MMP Expression, Cleavage of Checkpoint Molecules and T Cell Activity
by: Eric J. Lebish, et al.
Published: (2022-12-01) -
MK2 Promotes the Development and Progression of Pancreatic Neuroendocrine Tumors Mediated by Macrophages and Metabolomic Factors
by: Damian Jacenik, et al.
Published: (2022-11-01)